Abstract |
Pathway deregulation has been identified as a key driver of carcinogenesis, with proteins in signaling pathways serving as primary targets for drug development. Deregulation can be driven by a number of molecular events, including gene mutation, epigenetic changes in gene promoters, overexpression, and gene amplifications or deletions. We demonstrate a novel approach that identifies pathways of interest by integrating outlier analysis within and across molecular data types with gene set analysis. We use the results to seed the top-scoring pair algorithm to identify robust biomarkers associated with pathway deregulation. We demonstrate this methodology on pediatric acute myeloid leukemia (AML) data. We develop a biomarker in primary AML tumors, demonstrate robustness with an independent primary tumor data set, and show that the identified biomarkers also function well in relapsed pediatric AML tumors.
|
Authors | Michael F Ochs, Jason E Farrar, Michael Considine, Yingying Wei, Soheil Meshinchi, Robert J Arceci |
Journal | IEEE/ACM transactions on computational biology and bioinformatics
(IEEE/ACM Trans Comput Biol Bioinform)
2014 May-Jun
Vol. 11
Issue 3
Pg. 520-32
ISSN: 1557-9964 [Electronic] United States |
PMID | 26356020
(Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
|
Chemical References |
|
Topics |
- Algorithms
- Biomarkers, Tumor
(analysis, genetics, metabolism)
- Child
- Gene Expression Profiling
(methods)
- Genomics
(methods)
- Humans
- Leukemia, Myeloid
(genetics, metabolism)
- Methylation
- Models, Statistical
- Signal Transduction
|